Hyperfine (HYPR) Non-Current Deffered Revenue (2021 - 2026)
Hyperfine (HYPR) posted Non-Current Deffered Revenue of $713000.0 for Q1 2026, down 2.19% on a QoQ basis from $729000.0 in Q4 2025, and down 30.64% year-over-year from $1.0 million in Q1 2025.
Hyperfine (HYPR) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Hyperfine's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $713000.0 for Q1 2026.
- Quarterly Non-Current Deffered Revenue fell 30.64% year-over-year to $713000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $713000.0 (down 30.64% YoY) and the FY2025 annual result came in at $729000.0, down 30.83% from the prior year.
- Non-Current Deffered Revenue was $713000.0 for Q1 2026 at Hyperfine, down from $729000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $1.5 million in Q4 2022 and bottomed at $713000.0 in Q1 2026.
- A 5-year average of $1.0 million and a median of $1.0 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue soared 199.22% — and 2023, when it plunged 36.57%.
- Hyperfine's Non-Current Deffered Revenue stood at $1.5 million in 2022, then plunged by 36.57% to $968000.0 in 2023, then increased by 8.88% to $1.1 million in 2024, then sank by 30.83% to $729000.0 in 2025, then slipped by 2.19% to $713000.0 in 2026.
- Business Quant data shows HYPR's Non-Current Deffered Revenue at $713000.0 in Q1 2026, $729000.0 in Q4 2025, and $974000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 713,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 713,000.00 |
| Dec 31, 2025 | 729,000.00 |
| Sep 30, 2025 | 974,000.00 |
| Jun 30, 2025 | 914,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 968,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 889,000.00 |
| Jun 30, 2022 | 745,000.00 |
| Mar 31, 2022 | 851,000.00 |
| Dec 31, 2021 | 510,000.00 |